Search This Blog

Wednesday, February 12, 2020

CRISPR Therapeutics EPS beats by $1.19, beats on revenue

CRISPR Therapeutics (NASDAQ:CRSP): Q4 GAAP EPS of $0.51 beats by $1.19.
Revenue of $77.02M (+64083.3% Y/Y) beats by $37.94M.
Press Release
https://seekingalpha.com/news/3541366-crispr-therapeutics-eps-beats-1_19-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)